IBT
TSRO

International Biotechnology Trust’s TESARO, Inc. TSRO Stock Holding History

International Biotechnology Trust’s Portfolio TSRO Stock Details TSRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-21,300
Closed -$1.22M – 67
2018
Q1 		$1.22M Sell
21,300
-56,000
-72% -$3.6M 0.47% 46
2017
Q4 		$6.41M Buy
77,300
+42,300
+121% +$4.15M 2.26% 15
2017
Q3 		$4.52M Buy
35,000
+1,500
+4% +$186K 1.76% 20
2017
Q2 		$4.68M Buy
33,500
+10,000
+43% +$1.45M 1.78% 18
2017
Q1 		$3.62M Sell
23,500
-71,000
-75% -$11.6M 1.38% 21
2016
Q4 		$12.7M Buy
+94,500
New +$11.9M 5.72% 5

Other funds holding TSRO

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

International Biotechnology Trust's TSRO Position: Q2 2018 in Review

International Biotechnology Trust sold out of TESARO, Inc. (TSRO) in Q2 2018, closing a stake of 21,300 shares — an estimated $1.22M sold.

International Biotechnology Trust first reported a position in TSRO in Q4 2016 and held it in 6 quarters. The position peaked at $12.7M in Q4 2016. 200 funds tracked by Wall St. Rank hold TSRO as of Q2 2018.

  • International Biotechnology Trust reported no remaining TESARO, Inc. position as of Q2 2018 after selling out during the quarter.
  • International Biotechnology Trust sold 21,300 TESARO, Inc. shares in Q2 2018, an estimated $1.22M.
  • International Biotechnology Trust first reported a position in TESARO, Inc. in Q4 2016 and held it in 6 quarters.
  • International Biotechnology Trust's TESARO, Inc. position peaked at $12.7M in Q4 2016.
  • 200 funds tracked by Wall St. Rank held TESARO, Inc. as of Q2 2018.

Based on International Biotechnology Trust's 13F filing for Q2 2018, filed 13 Aug 2018.